rs482204

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198407.2(GHSR):​c.*122C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.714 in 1,091,134 control chromosomes in the GnomAD database, including 281,179 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 35419 hom., cov: 31)
Exomes 𝑓: 0.72 ( 245760 hom. )

Consequence

GHSR
NM_198407.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.60

Publications

6 publications found
Variant links:
Genes affected
GHSR (HGNC:4267): (growth hormone secretagogue receptor) This gene encodes a member of the G-protein coupled receptor family. The encoded protein may play a role in energy homeostasis and regulation of body weight. Two identified transcript variants are expressed in several tissues and are evolutionary conserved in fish and swine. One transcript, 1a, excises an intron and encodes the functional protein; this protein is the receptor for the Ghrelin ligand and defines a neuroendocrine pathway for growth hormone release. The second transcript (1b) retains the intron and does not function as a receptor for Ghrelin; however, it may function to attenuate activity of isoform 1a. Mutations in this gene are associated with autosomal idiopathic short stature.[provided by RefSeq, Apr 2010]
GHSR Gene-Disease associations (from GenCC):
  • short stature due to GHSR deficiency
    Inheritance: AD, SD, AR Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 3-172445039-G-A is Benign according to our data. Variant chr3-172445039-G-A is described in ClinVar as Benign. ClinVar VariationId is 344196.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.739 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GHSRNM_198407.2 linkc.*122C>T 3_prime_UTR_variant Exon 2 of 2 ENST00000241256.3 NP_940799.1 Q92847-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GHSRENST00000241256.3 linkc.*122C>T 3_prime_UTR_variant Exon 2 of 2 1 NM_198407.2 ENSP00000241256.2 Q92847-1

Frequencies

GnomAD3 genomes
AF:
0.679
AC:
102909
AN:
151570
Hom.:
35407
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.576
Gnomad AMI
AF:
0.691
Gnomad AMR
AF:
0.717
Gnomad ASJ
AF:
0.683
Gnomad EAS
AF:
0.640
Gnomad SAS
AF:
0.499
Gnomad FIN
AF:
0.697
Gnomad MID
AF:
0.722
Gnomad NFE
AF:
0.744
Gnomad OTH
AF:
0.704
GnomAD4 exome
AF:
0.720
AC:
676064
AN:
939446
Hom.:
245760
AF XY:
0.712
AC XY:
345791
AN XY:
485810
show subpopulations
African (AFR)
AF:
0.584
AC:
13359
AN:
22856
American (AMR)
AF:
0.756
AC:
31077
AN:
41124
Ashkenazi Jewish (ASJ)
AF:
0.696
AC:
15045
AN:
21628
East Asian (EAS)
AF:
0.661
AC:
24520
AN:
37082
South Asian (SAS)
AF:
0.517
AC:
37140
AN:
71796
European-Finnish (FIN)
AF:
0.698
AC:
29838
AN:
42762
Middle Eastern (MID)
AF:
0.726
AC:
3114
AN:
4292
European-Non Finnish (NFE)
AF:
0.751
AC:
491399
AN:
654760
Other (OTH)
AF:
0.709
AC:
30572
AN:
43146
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
9593
19186
28780
38373
47966
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9180
18360
27540
36720
45900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.679
AC:
102972
AN:
151688
Hom.:
35419
Cov.:
31
AF XY:
0.674
AC XY:
50005
AN XY:
74146
show subpopulations
African (AFR)
AF:
0.576
AC:
23768
AN:
41268
American (AMR)
AF:
0.716
AC:
10927
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.683
AC:
2366
AN:
3464
East Asian (EAS)
AF:
0.640
AC:
3310
AN:
5172
South Asian (SAS)
AF:
0.499
AC:
2408
AN:
4822
European-Finnish (FIN)
AF:
0.697
AC:
7337
AN:
10522
Middle Eastern (MID)
AF:
0.718
AC:
211
AN:
294
European-Non Finnish (NFE)
AF:
0.744
AC:
50531
AN:
67876
Other (OTH)
AF:
0.705
AC:
1487
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1644
3289
4933
6578
8222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.663
Hom.:
5396
Bravo
AF:
0.683
Asia WGS
AF:
0.557
AC:
1941
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Short stature due to growth hormone secretagogue receptor deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.011
DANN
Benign
0.33
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs482204; hg19: chr3-172162829; API